|
|
||||||||
From the Hôpital A Boulloche (Drs. Bataillard, Rumbach, and Tournade), Montbéliard cedex; Unité INSERM U523, Institut de Myologie (Drs. Chatzoglou, Laforêt, and Lombès), Service de Biochimie B (Drs. Sternberg and Jardel), and the Service de Neuropathologie (Dr. Maisonobe), Hôpital de La Salpêtrière, Paris, France.
Address correspondence and reprint requests to Dr. A. Lombès, INSERM UR 523, Institut de Myologie, Hôpital de La Salpêtrière, 75651 Paris cedex 13, France; e-mail: a.lombes{at}myologie.chups.jussieu.fr
The authors studied a 47-year-old patient who presented with an association of deafness, acute cerebral stroke-like episode, leukoencephalopathy, and extensive basal ganglia calcifications. Late onset and neuroradiologic findings were atypical for MELAS syndrome (Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike episodes). A heteroplasmic G to A transition at nucleotide 4332 in the tRNA glutamine gene was identified in the patients muscle mitochondrial DNA. The pathogenicity of the mutation was shown in single muscle fibers by the correlation between high mutation load and cytochrome c oxidase defect.
This article has been cited by other articles:
![]() |
Y. Baba, D. F. Broderick, R. J. Uitti, M. L. Hutton, and Z. K. Wszolek Heredofamilial Brain Calcinosis Syndrome Mayo Clin. Proc., May 1, 2005; 80(5): 641 - 651. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |